Αthanasios Fassas

St. Luke's Hospital — Greece

Medicine · Health Sciences

39h-index7.1kcitations123works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(36), Hematopoietic Stem Cell Transplantation(24), Lymphoma Diagnosis and Treatment(22), Multiple Sclerosis Research Studies(20), Monoclonal and Polyclonal Antibodies Research(14)

Publications123 total

Inflammatory Pseudotumor of the Spleen in a Patient With Psoriatic Arthritis: A Diagnostic Challenge in the COVID-19 Era
Cureus·2024· 1 citedOpen Access
Splicing variants in hereditary cancer genes: clinical utility of functional RNA analysis
2020
Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
2019· 15 cited
Tracking the VIX
The Journal of Index Investing·2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
JAMA Neurology·2017· 265 citedOpen Access
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
JAMA·2014· 725 citedOpen Access
in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene Geographic patterns and pathogenetic implications of IGHV gene usage
2013
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry
Lupus·2012· 90 cited
Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial
Blood·2012· 9 cited
Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis
Annals of the Rheumatic Diseases·2012· 116 cited
Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor
Blood·2011· 1 cited
Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
Molecular Therapy·2011· 63 citedOpen Access
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
Blood·2011· 168 citedOpen Access
Diagnosis of Lupus, age at HSCT and CD34+graft selection are the main risk factors for secondary autoimmune diseases occurring after HSCT for autoimmune diseases: a retrospective study of the EBMT Autoimmune Disease Working Party
Data Archiving and Networked Services (DANS)·2011
Long-term results of stem cell transplantation for MS
Neurology·2011· 89 cited
Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study
Blood·2010
Successful Hematopoietic STEM CELL Mobilization with GRANULOCYTE Colony Stimulating FACTOR PLUS Plerixafor (MOZOBIL, AMD3100) IN POOR Mobilizers: A Single CENTER STUDY
Blood·2010
OUTCOME of Allogeneic Hematopoietic CELL TRANSPLANTATION for AML: A Single CENTER Retrospective ANALYSIS.
Blood·2010
Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy
Blood·2010
Risks of Immune System Treatments
Science·2010· 24 cited
page 1 of 7Next →

Frequent Co-authors

Αchilles Anagnostopoulos(27), Κώστας Σταματόπουλος(12), Riccardo Saccardi(9), Alan Tyndall(9), Dominique Farge(8), Chrysoula Belessi(8), Niki Stavroyianni(8), Nikolaos Laoutaris(8), Vasilios Κ. Kimiskidis(8), Tomáš Kozák(7), Aloïs Gratwohl(6), Anastasia Hadzidimitriou(6), Jakob Passweg(6), John A. Snowden(6), Tatjana Smilevska(5), Evangelia Yannaki(5), A. Kazis(5), Ioanna Sakellari(5), Aliki Tsompanakou(5), Gianluigi Mancardi(5)